Targeting Hepatitis B Virus with CRISPR/Cas9

Molecular Therapy Nucleic Acids

Volumn 3, Issue , 2014, Pages e216-

  Seeger, Christoph ^a   Sohn, Ji A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Antiviral therapy; Chronic hepatitis B; Covalently closed circular dna; CRISPR Cas9; Hepatitis B virus; Nonhomologous end joining

Indexed keywords

ALPHA INTERFERON; CASPASE 9; CIRCULAR DNA; EXTRACHROMOSOMAL DNA; GENOMIC RNA; GUIDE RNA; HEPATITIS B CORE ANTIGEN; LENTIVIRUS VECTOR; SODIUM BILE ACID COTRANSPORTER; TRANSFER RNA; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA; COVALENTLY CLOSED CIRCULAR DNA; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ARTICLE; CELL LEVEL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CYTOKINE PRODUCTION; DNA CLEAVAGE; DNA END JOINING REPAIR; DNA TEMPLATE; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE EXPRESSION; GENE TARGETING; HEPATITIS B; HEPATITIS B VIRUS; HEPG2 CELL LINE; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS REPLICATION; ANTIVIRAL ACTIVITY; CHROMOSOME; CONTROLLED STUDY; GENE MUTATION;

EID: 84927935415     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2014.68     Document Type: Article

References (44)

1. Liaw, YF and Chu, CM (2009). Hepatitis B virus infection. Lancet 373: 582-592.
2. Lozano, R, Naghavi, M, Foreman, K, Lim, S, Shibuya, K, Aboyans, V et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
3. Trépo, C, Chan, HL and Lok, A (2014). Hepatitis B virus infection. Lancet (epub ahead of print).
4. Seeger, C and Mason, WS (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
5. Seeger, C, Zoulim, F and Mason, WS (2013). Hepadnaviruses. In: Knipe, DM, Howley, P (eds). Lippincott, Williams and Wilkins: Philadelphia, PA Fields Virology 6th edition pp.2185-2221.
6. Sohn, JA, Litwin, S and Seeger, C (2009). Mechanism for CCC DNA synthesis in hepadnaviruses. PLoS One 4: e8093.
7. Newbold, JE, Xin, H, Tencza, M, Sherman, G, Dean, J, Bowden, S et al. (1995). The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 69: 3350-3357.
8. Summers, J and Mason, WS (1982). Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403-415.
9. Seeger, C, Ganem, D and Varmus, HE (1986). Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232: 477-484.
10. Tuttleman, JS, Pourcel, C and Summers, J (1986). Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47: 451-460.
11. Lenhoff, RJ and Summers, J (1994). Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J Virol 68: 5706-5713.
12. Moraleda, G, Saputelli, J, Aldrich, CE, Averett, D, Condreay, L and Mason, WS (1997). Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 71: 9392-9399.
13. Zhu, Y, Yamamoto, T, Cullen, J, Saputelli, J, Aldrich, CE, Miller, DS et al. (2001). Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 75: 311-322.
14. Guo, JT, Pryce, M, Wang, X, Barrasa, MI, Hu, J and Seeger, C (2003). Conditional replication of duck hepatitis B virus in hepatoma cells. J Virol 77: 1885-1893.
15. Reaiche-Miller, GY, Thorpe, M, Low, HC, Qiao, Q, Scougall, CA, Mason, WS et al. (2013). Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. Virology 446: 357-364.
16. Guidotti, LG, Rochford, R, Chung, J, Shapiro, M, Purcell, R and Chisari, FV (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
17. Murray, JM, Wieland, SF, Purcell, RH and Chisari, FV (2005). Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA 102: 17780-17785.
18. Kajino, K, Jilbert, AR, Saputelli, J, Aldrich, CE, Cullen, J and Mason, WS (1994). Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 68: 5792-5803.
19. Guo, JT, Zhou, H, Liu, C, Aldrich, C, Saputelli, J, Whitaker, T et al. (2000). Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol 74: 1495-1505.
20. Summers, J, Jilbert, AR, Yang, W, Aldrich, CE, Saputelli, J, Litwin, S et al. (2003). Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci USA 100: 11652-11659.
21. Lucifora, J, Xia, Y, Reisinger, F, Zhang, K, Stadler, D, Cheng, X et al. (2014). Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343: 1221-1228.
22. Chisari, FV, Mason, WS and Seeger, C (2014). Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA". Science 344: 1237.
23. Yan, H, Zhong, G, Xu, G, He, W, Jing, Z, Gao, Z et al. (2012). Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1: e00049.
24. Seeger, C and Mason, WS (2013). Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus. Gut 62: 1093-1095.
25. Ran, FA, Hsu, PD, Wright, J, Agarwala, V, Scott, DA and Zhang, F (2013). Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8: 2281-2308.
26. Hsu, PD, Lander, ES and Zhang, F (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262-1278.
27. Wang, T, Wei, JJ, Sabatini, DM and Lander, ES (2014). Genetic screens in human cells using the CRISPR-Cas9 system. Science 343: 80-84.
28. Ladner, SK, Otto, MJ, Barker, CS, Zaifert, K, Wang, GH, Guo, JT et al. (1997). Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41: 1715-1720.
29. Guschin, DY, Waite, AJ, Katibah, GE, Miller, JC, Holmes, MC and Rebar, EJ (2010). A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol 649: 247-256.
30. Bloom, K, Ely, A, Mussolino, C, Cathomen, T and Arbuthnot, P (2013). Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 21: 1889-1897.
31. Weber, ND, Stone, D, Sedlak, RH, De Silva Feelixge, HS, Roychoudhury, P, Schiffer, JT et al. (2014). AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication. PLoS One 9: e97579.
32. Cradick, TJ, Keck, K, Bradshaw, S, Jamieson, AC and McCaffrey, AP (2010). Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther 18: 947-954.
33. Guo, H, Xu, C, Zhou, T, Block, TM and Guo, JT (2012). Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation. PLoS One 7: e43270.
34. Staprans, S, Loeb, DD and Ganem, D (1991). Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol 65: 1255-1262.
35. Cho, SW, Kim, S, Kim, JM and Kim, JS (2013). Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 230-232.
36. Fu, Y, Foden, JA, Khayter, C, Maeder, ML, Reyon, D, Joung, JK et al. (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31: 822-826.
37. Hsu, PD, Scott, DA, Weinstein, JA, Ran, FA, Konermann, S, Agarwala, V et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31: 827-832.
38. Belloni, L, Pollicino, T, De Nicola, F, Guerrieri, F, Raffa, G, Fanciulli, M et al. (2009). Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA 106: 19975-19979.
39. Lucifora, J, Arzberger, S, Durantel, D, Belloni, L, Strubin, M, Levrero, M et al. (2011). Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55: 996-1003.
40. Van Breugel, PC, Robert, EI, Mueller, H, Decorsière, A, Zoulim, F, Hantz, O et al. (2012). Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates. Hepatology 56: 2116-2124.
41. Suspène, R, Guétard, D, Henry, M, Sommer, P, Wain-Hobson, S and Vartanian, JP (2005). Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 102: 8321-8326.
42. Hirt, B (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369.
43. Yang, W, Mason, WS and Summers, J (1996). Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J Virol 70: 4567-4575.
44. Levin, BC, Cheng, H and Reeder, DJ (1999). A human mitochondrial DNA standard reference material for quality control in forensic identification, medical diagnosis, and mutation detection. Genomics 55: 135-146.